High dose albumin (drug) in liver disease.
Not Applicable
- Conditions
- Health Condition 1: K746- Other and unspecified cirrhosis ofliver
- Registration Number
- CTRI/2023/07/055888
- Lead Sponsor
- Takeda Pharmaceuticals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients with acute decompensation of cirrhosis
2.Patients with age from 18-65 years
Exclusion Criteria
1.Recent Gastrointestinal bleeding within 7 days
2.Patients with organic nephropathy (as defined by IAC)
3.Patients with Cardiovascular disease or chronic obstructive pulmonary disease
4.Systemic arterial hypertension ( >160/90mmhg)
5.Presence of hepatocellular carcinoma (outside Milan criteria) ( or portal vein thrombosis
6.Budd-Chiari Syndrome
7.Pregnancy
8.Patients with serum albumin >3 gm
9.Refusal to participate
10.Known or suspected hypersensitivity to albumin
11.Prior TIPS
12.Post liver or kidney transplantation
13.Patients enrolled in other clinical trials
14.Extrahepatic malignancy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method